Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice

Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2017-05, Vol.58, p.1101
Hauptverfasser: Li, Ming-Hsin, Shiue, Chyng-Yann, Chang, Han-Chih, Feng, Chun-Fang, Chang, Chih-Hsien
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 1101
container_title The Journal of nuclear medicine (1978)
container_volume 58
creator Li, Ming-Hsin
Shiue, Chyng-Yann
Chang, Han-Chih
Feng, Chun-Fang
Chang, Chih-Hsien
description Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2039865117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2039865117</sourcerecordid><originalsourceid>FETCH-proquest_journals_20398651173</originalsourceid><addsrcrecordid>eNqNyr0KwjAUQOEgCtafd7jgHEgsN4ljqS120EHdS9C0ptREm1bw7XXwAZzO8J0RiTjGSFEIOSYR44JTRIZTMguhYYwJpVREitPb9TcTbADtrmBeuh10b70DX0FOuaLFITtSjlKCDrDbJqmF4q5r62pIauN6sA729mIWZFLpNpjlr3OyyrNzuqOPzj8HE_qy8UPnvlSuWbxRAjmX8X_XB-l5Ojw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2039865117</pqid></control><display><type>article</type><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</creator><creatorcontrib>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</creatorcontrib><description>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><language>eng</language><publisher>New York: Society of Nuclear Medicine</publisher><subject>Benzamide ; Biphenyl ; Bombardment ; Cancer ; Chemical synthesis ; Histone deacetylase ; In vivo methods and tests ; Neurological diseases ; Neurological disorders ; Nuclear medicine ; Organic chemistry ; Precursors ; Proteins ; Radioactivity ; Radiochemistry ; Therapeutic applications</subject><ispartof>The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.1101</ispartof><rights>Copyright Society of Nuclear Medicine May 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Li, Ming-Hsin</creatorcontrib><creatorcontrib>Shiue, Chyng-Yann</creatorcontrib><creatorcontrib>Chang, Han-Chih</creatorcontrib><creatorcontrib>Feng, Chun-Fang</creatorcontrib><creatorcontrib>Chang, Chih-Hsien</creatorcontrib><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><title>The Journal of nuclear medicine (1978)</title><description>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</description><subject>Benzamide</subject><subject>Biphenyl</subject><subject>Bombardment</subject><subject>Cancer</subject><subject>Chemical synthesis</subject><subject>Histone deacetylase</subject><subject>In vivo methods and tests</subject><subject>Neurological diseases</subject><subject>Neurological disorders</subject><subject>Nuclear medicine</subject><subject>Organic chemistry</subject><subject>Precursors</subject><subject>Proteins</subject><subject>Radioactivity</subject><subject>Radiochemistry</subject><subject>Therapeutic applications</subject><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNyr0KwjAUQOEgCtafd7jgHEgsN4ljqS120EHdS9C0ptREm1bw7XXwAZzO8J0RiTjGSFEIOSYR44JTRIZTMguhYYwJpVREitPb9TcTbADtrmBeuh10b70DX0FOuaLFITtSjlKCDrDbJqmF4q5r62pIauN6sA729mIWZFLpNpjlr3OyyrNzuqOPzj8HE_qy8UPnvlSuWbxRAjmX8X_XB-l5Ojw</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Li, Ming-Hsin</creator><creator>Shiue, Chyng-Yann</creator><creator>Chang, Han-Chih</creator><creator>Feng, Chun-Fang</creator><creator>Chang, Chih-Hsien</creator><general>Society of Nuclear Medicine</general><scope>4T-</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20170501</creationdate><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><author>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20398651173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Benzamide</topic><topic>Biphenyl</topic><topic>Bombardment</topic><topic>Cancer</topic><topic>Chemical synthesis</topic><topic>Histone deacetylase</topic><topic>In vivo methods and tests</topic><topic>Neurological diseases</topic><topic>Neurological disorders</topic><topic>Nuclear medicine</topic><topic>Organic chemistry</topic><topic>Precursors</topic><topic>Proteins</topic><topic>Radioactivity</topic><topic>Radiochemistry</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Ming-Hsin</creatorcontrib><creatorcontrib>Shiue, Chyng-Yann</creatorcontrib><creatorcontrib>Chang, Han-Chih</creatorcontrib><creatorcontrib>Feng, Chun-Fang</creatorcontrib><creatorcontrib>Chang, Chih-Hsien</creatorcontrib><collection>Docstoc</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Ming-Hsin</au><au>Shiue, Chyng-Yann</au><au>Chang, Han-Chih</au><au>Feng, Chun-Fang</au><au>Chang, Chih-Hsien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><date>2017-05-01</date><risdate>2017</risdate><volume>58</volume><spage>1101</spage><pages>1101-</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><abstract>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</abstract><cop>New York</cop><pub>Society of Nuclear Medicine</pub></addata></record>
fulltext fulltext
identifier ISSN: 0161-5505
ispartof The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.1101
issn 0161-5505
1535-5667
language eng
recordid cdi_proquest_journals_2039865117
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Benzamide
Biphenyl
Bombardment
Cancer
Chemical synthesis
Histone deacetylase
In vivo methods and tests
Neurological diseases
Neurological disorders
Nuclear medicine
Organic chemistry
Precursors
Proteins
Radioactivity
Radiochemistry
Therapeutic applications
title Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A15%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20F-18-INER-1577%20as%20HDACi%20Imaging%20Agent%20in%20Mice&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Li,%20Ming-Hsin&rft.date=2017-05-01&rft.volume=58&rft.spage=1101&rft.pages=1101-&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/&rft_dat=%3Cproquest%3E2039865117%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2039865117&rft_id=info:pmid/&rfr_iscdi=true